According to US health officials, one in about 100,000 people has experienced a severe allergic reaction after receiving a dose of Pfizer-BioNTech vaccine.

"On average, this represents a rate of 11.1 anaphylactic shocks per million doses administered."

One in about 100,000 people has experienced a severe allergic reaction after receiving a dose of Pfizer-BioNTech's coronavirus vaccine, US health officials said on Wednesday, stressing that the benefits of the vaccination far outweigh the potential risks.

The figure was calculated by the Centers for Disease Prevention and Control (CDC), which identified 21 cases of anaphylactic shock, a severe allergic reaction, out of a total of 1,893,360 injections of the vaccine made between the 14th and the 14th. December 23.

>> LIVE -

Coronavirus: follow the evolution of the situation Thursday, January 7

"11.1 anaphylactic shocks per million doses administered" on average

"On average, this represents a rate of 11.1 anaphylactic shocks per million doses administered," Nancy Messonnier, a CDC official, told reporters.

For comparison, influenza vaccines cause about 1.3 anaphylactic shock per million doses.

Even though the rate for Pfizer-BioNTech's coronavirus vaccine is about ten times higher, the number of cases of severe allergic reactions remains "exceedingly rare" and the population has every interest in being vaccinated, the risks of the pandemic of Covid-19 being much larger, insisted Nancy Messonnier.


"We know how to treat anaphylactic shock and we have put in place procedures at the vaccination sites" to react if necessary, she added.

The 21 cases identified by the CDC involved people aged 27 to 60, with a median age of 40.

All but two were treated with epinephrine, which is commonly used to treat severe allergies.

19 cases (90%) of allergic shock involved women and symptoms occurred between two and 150 minutes after vaccine injection (median time 13 minutes).

These symptoms included rash, hives, a feeling of suffocation, swelling of the tongue, difficulty breathing, swollen lips, nausea, and a persistent dry cough.


Four patients (19%) were hospitalized, including three in intensive care, and the other 17 were treated in an emergency department.

CORONAVIRUS ESSENTIALS

> Covid-19 vaccines: what do we really know about their side effects?

> What do we know about "long Covid", these patients who are going through hell?

> These three facets of the coronavirus that you may not have heard of

> When are we in contact?

And other questions that we ask ourselves every day

> Coronavirus: the 5 mistakes not to make with your mask

No deaths to be deplored

There were no deaths and all but one were well at the time of the study.

Ms Messonnier said investigations were underway to determine the cause of the allergic reactions.

One of the hypotheses concerns the presence in the vaccine of a substance, polyethylene glycol (PEG), which is used in many common products such as laxatives, shampoos or toothpaste but has never yet been used in vaccines.

Currently, the US authorities have authorized two vaccines, one developed by Pfizer and another produced by Moderna.

Both use a new technology, called messenger RNA (mRNA), which had never been approved in a vaccine until now, and contain PEG.

There is still insufficient data to determine the rate of anaphylactic shock after injection of Moderna vaccine.